Recent

% | $
Quotes you view appear here for quick access.

Vringo, Inc. Message Board

edvacourt 3 posts  |  Last Activity: Jan 28, 2015 1:46 PM Member since: Oct 23, 2012
  • Very good call. Being more conservative would have served them well last year. They had explosive growth but because they ridiculously blue skied their numbers they paid a price when they should have been applauded. Regardless, I'll take better than 40% growth for 2015 all day long. Once the Q1 orders are announced (who they are) this will really gain steam. Should have bounced anyway in my view but people go into these calls with expectations about what will be said and if the stock doesn't pop they sell. After we get the passive guys out this will move up. My opinion only.

    Sentiment: Strong Buy

  • edvacourt edvacourt Jan 28, 2015 1:33 PM Flag

    It's an exercise in futility to do that. That is the problem with stock investments these days. Anyone with a "fund" who has a plausible background can scream fire about any stock. Since Left's entire take was backward looking, and PLUG's history was ugly, it had legs. The only way for PLUG to stay relevant over the long term is to produce. They do need to hit their numbers and they should have been smart enough to know that when they got too feverish with their estimates last year. The blame for that is squarely on Andy. No way this stock shouldn't be up after the call I heard but it will be for sure after he announces the first of the two Q1 orders.

    Sentiment: Strong Buy

  • edvacourt by edvacourt Dec 31, 2014 11:57 AM Flag

    Great news released in 8-K this morning on the Ebola Study. The FDA doesn't approve stuff like that unless there is justification for it. Remember that the DETECT CTE study results are due out in January in coordination with Boston University. Keep in mind there has never been a way to test for that disease on live patients, only autopsy. That will be yet another breakthrough. Best to all in 2015!

    Sentiment: Strong Buy

VRNG
0.6599-0.0200(-2.94%)11:33 AMEDT